During HD Awareness Month, Teva Announces News About Single Tablet, Once a Day Austedo XR!katrina4384Jun 12, 20240 min readHD Community Letter.pdfDownload PDF • 215KB
Skyhawk Therapeutics Announces First U.S. Patients Dosed in Pivotal FALCON-HD Study Evaluating SKY-0515 in Huntington's Disease
uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington’s Disease
Comments